• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec14
Marex Group Invests 1,002,000 USD in TG Therapeutics
11:51
Nov5
Company Announces Q3 2025 Earnings Beat, Plans Continued Commercialization of BRIUMVI
22:12
Nov3
TG Therapeutics Reports Exceeding Expectations in Briumvi Revenue and Upgrading 2025 Revenue Guidance
19:06
TG Therap released FY2025 9 Months Earnings on November 3 Pre-Market EST, Actual Revenue: USD 423.71 M, Actual EPS: USD 2.6299
14:30
TG Therap released FY2025 Q3 earnings on November 3 Pre-Market (EST), actual revenue USD 161.71 M (forecast USD 152.17 M), actual EPS USD 2.4299 (forecast USD 0.2201)
14:30
Oct28
TG Therapeutics Completes Phase 3 ENHANCE Trial Enrollment for BRIUMVI® New Regimen for Relapsing MS
11:30

Schedules & Filings

Schedules
Filings
Nov3
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 161.71 M, Net Income 390.9 M, EPS 2.4299

Aug4
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 141.15 M, Net Income 28.19 M, EPS 0.17

May5
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 120.86 M, Net Income 5.06 M, EPS 0.0299

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More